121 related articles for article (PubMed ID: 23331161)
1. Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.
Patel V; Buckstein M; Perini R; Hill-Kayser C; Svoboda J; Plastaras JP
Leuk Lymphoma; 2013 Oct; 54(10):2168-76. PubMed ID: 23331161
[TBL] [Abstract][Full Text] [Related]
2. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
[TBL] [Abstract][Full Text] [Related]
4. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
[TBL] [Abstract][Full Text] [Related]
5. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
[TBL] [Abstract][Full Text] [Related]
6. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
Voss SD; Chen L; Constine LS; Chauvenet A; Fitzgerald TJ; Kaste SC; Slovis T; Schwartz CL
J Clin Oncol; 2012 Jul; 30(21):2635-40. PubMed ID: 22689804
[TBL] [Abstract][Full Text] [Related]
7. Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.
Guttikonda R; Herts BR; Dong F; Baker ME; Fenner KB; Pohlman B
Eur J Radiol; 2014 Jun; 83(6):1011-1015. PubMed ID: 24656401
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.
El-Galaly T; Prakash V; Christiansen I; Madsen J; Johansen P; Boegsted M; Johnsen HE; Bukh A
Leuk Lymphoma; 2011 Apr; 52(4):597-603. PubMed ID: 21314488
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Hodgkin lymphoma: are we over-scanning our patients?
Rathore N; Eissa HM; Margolin JF; Liu H; Wu MF; Horton T; Kamdar K; Dreyer Z; Steuber P; Rabin KR; Redell M; Allen CE; McClain KL; Guillerman RP; Bollard CM
Pediatr Hematol Oncol; 2012 Aug; 29(5):415-23. PubMed ID: 22632168
[TBL] [Abstract][Full Text] [Related]
11. Positron Emission Tomography Scanning in the Management of Hodgkin Lymphoma Patients: A Single-Institution Experience.
Zabrocka E; Sierko E; Wojtukiewicz MZ
Adv Clin Exp Med; 2016; 25(6):1185-1192. PubMed ID: 28028972
[TBL] [Abstract][Full Text] [Related]
12. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
Pingali SR; Jewell SW; Havlat L; Bast MA; Thompson JR; Eastwood DC; Bartlett NL; Armitage JO; Wagner-Johnston ND; Vose JM; Fenske TS
Cancer; 2014 Jul; 120(14):2122-9. PubMed ID: 24711253
[TBL] [Abstract][Full Text] [Related]
13. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Lee AI; Zuckerman DS; Van den Abbeele AD; Aquino SL; Crowley D; Toomey C; Lacasce AS; Feng Y; Neuberg DS; Hochberg EP
Cancer; 2010 Aug; 116(16):3835-42. PubMed ID: 20564135
[TBL] [Abstract][Full Text] [Related]
14. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
Cerci JJ; Trindade E; Buccheri V; Fanti S; Coutinho AM; Zanoni L; Linardi CC; Celli M; Delbeke D; Pracchia LF; Pitela FA; Soares J; Zinzani PL; Meneghetti JC
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):314-20. PubMed ID: 21816369
[TBL] [Abstract][Full Text] [Related]
15. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission.
Glober G; Gunther J; Fang P; Milgrom S; Korivi BR; Jensen CT; Wagner-Bartak NA; Ahmed S; Lee HJ; Nair R; Steiner R; Parmar S; Iyer S; Westin J; Fayad L; Rodriguez MA; Neelapu S; Nastoupil L; Flowers CR; Dabaja BS; Pinnix CC
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):533-541. PubMed ID: 32291233
[TBL] [Abstract][Full Text] [Related]
16. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
[TBL] [Abstract][Full Text] [Related]
17. 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Kahraman D; Theurich S; Rothe A; Kuhnert G; Sasse S; Scheid C; Dietlein M; Drzezga A; von Bergwelt-Baildon M; Kobe C
Leuk Lymphoma; 2014 Apr; 55(4):811-6. PubMed ID: 23805904
[TBL] [Abstract][Full Text] [Related]
18. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.
El-Galaly TC; Hutchings M; Mylam KJ; Brown Pde N; Bukh A; Johnsen HE; Kamper P; Loft A; Iyer V; Gormsen LC; Nielsen AL; Bøgsted M; d'Amore F
Leuk Lymphoma; 2014 Oct; 55(10):2349-55. PubMed ID: 24354682
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?
Eissa HM; Allen CE; Kamdar K; Simko S; Goradia P; Dreyer Z; Steuber P; McClain KL; Guillerman RP; Bollard CM
Pediatr Hematol Oncol; 2014 Apr; 31(3):253-7. PubMed ID: 24087880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
